I think it is pretty good. He doesn't seem to know that CytodynE is presenting at the Barcelona ESMO CRC conference, so it's not included in near-term catalysts, and he also neglects to mention the option to add an ICI to the CRC trial, but he does note that Leron could broaden the ICI market in general, and he does know CytodynE changed the protocol of the CRC trial to include PD-L1. I wonder if the extra E on Cytodyn sometimes but not all the time means it is actually NOT AI generated?..... Naah. It must be Chat's work.